Aphria

(NASDAQ: APHA)
Healthcare  |  Drug Manufacturers—Specialty & Generic
4.28 -0.1565 -3.52%
Stock Price | Sept. 24, 2020, 2:44 p.m.
6 Followers
Bid: 4.28
Ask: 4.29
Prev. Close: 4.44
52 Week Low: 1.95
52 Week High: 6.2397
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not currently operate in the U.S. due to federal prohibition. The company is focusing on expanding through international cultivation and distribution into the global medical cannabis market. Aphria also offers multiple products under a portfolio of recreational cannabis brands, including Solei, RIFF, and Broken Coast.

Read more Read less

Recently Viewed Tickers

Premium Cannabis Stocks Review - AM Edition 09/09/20

4 Comments
2 weeks ago

Premium Cannabis Stocks Review - AM Edition 08/14/20

25 Comments
1 month ago

Premium Cannabis Stocks Review - AM Edition 08/11/20

14 Comments
1 month ago

Premium Weekly Review 08/07/20

1 month ago

Premium Cannabis Stocks Review - Pre-Market Edition 08/07/20

3 Comments
1 month ago

Premium Weekly Review 07/31/20

1 month ago

Premium Cannabis Stocks Review - Pre-Market Edition 07/30/20

8 Comments
1 month ago

Premium Cannabis Stocks Review - AM Edition 07/29/20

12 Comments
1 month ago

Premium Cannabis Stocks Review - Pre-Market Edition 07/29/20

10 Comments
1 month ago

Premium Cannabis Stocks Review - AM Edition 07/28/20

5 Comments
1 month ago